Therapeutic considerations about psittacosis: remarks on a case of family psittacosis.
Furneri
P M
PM
Institute of Microbiology, Catania, Italy.
Salerno
R
R
Barretti
C
C
Tandurella
S
S
Speciale
A M
AM
Caccamo
F
F
Lento
F G
FG
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial; D002171:Canaries / Q000382:microbiology; D002691:Chlamydophila psittaci / Q000276:immunology / Q000302:isolation & purification; D010856:Columbidae / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009956:Psittacosis / Q000175:diagnosis* / Q000188:drug therapy / Q000635:transmission; D013754:Tetracyclines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D013754:Tetracyclines